“๐๐ง ๐ญ๐จ๐๐๐ฒ’๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐ฆ๐๐ซ๐ค๐๐ญ, ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ข๐ฌ ๐ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐ฌ๐ญ๐๐ฉ ๐ข๐ง ๐ข๐๐๐ง๐ญ๐ข๐๐ฒ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐ซ๐๐๐ญ ๐ญ๐๐ซ๐ ๐๐ญ ๐๐จ๐ง๐ฌ๐ฎ๐ฆ๐๐ซ๐ฌ ๐๐ง๐ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ข๐ง๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ฌ๐๐ ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐๐ข๐ซ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐ง๐๐๐๐ฌ. ๐๐ก๐ข๐ฅ๐ ๐๐จ๐ซ๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐ง๐ ๐ญ๐ก๐๐ฌ๐ ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ฏ๐๐ซ๐ฒ ๐๐๐๐๐ญ ๐๐ง๐ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ฉ๐ซ๐จ๐๐ฅ๐๐ฆ ๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ญ๐ก๐ ๐ฉ๐๐ซ๐ญ๐ข๐๐ฎ๐ฅ๐๐ซ ๐ฌ๐๐๐ญ๐จ๐ซ ๐ข๐ฌ ๐ญ๐ก๐จ๐ซ๐จ๐ฎ๐ ๐ก๐ฅ๐ฒ ๐๐จ๐ง๐ฌ๐ข๐๐๐ซ๐๐. ๐๐ญ ๐๐ฅ๐ฌ๐จ ๐๐จ๐ง๐ฌ๐ข๐๐๐ซ๐ฌ ๐ง๐ฎ๐ฆ๐๐ซ๐จ๐ฎ๐ฌ ๐ ๐จ๐ฏ๐๐ซ๐ง๐ฆ๐๐ง๐ญ ๐ซ๐๐๐จ๐ซ๐ฆ๐ฌ, ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐ฏ๐ข๐ซ๐จ๐ง๐ฆ๐๐ง๐ญ, ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ ๐๐๐ก๐๐ฏ๐ข๐จ๐ฎ๐ซ, ๐๐ฎ๐ซ๐ซ๐๐ง๐ญ ๐๐ง๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ, ๐๐ง๐ ๐ซ๐๐ฉ๐ข๐๐ฅ๐ฒ ๐๐ก๐๐ง๐ ๐ข๐ง๐ ๐ญ๐๐๐ก๐ง๐ข๐๐๐ฅ ๐๐ซ๐๐๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐ฌ. ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ซ๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐ฉ๐ฅ๐๐ง๐ฌ ๐๐ง๐ ๐ฉ๐จ๐ฅ๐ข๐๐ข๐๐ฌ.”
The global bile duct cancer market is estimated to be valued at US$ 185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period (2021-2028).
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/4790
Global Bile Duct Cancer Market: Drivers
R&D of new drugs is expected to propel growth of the global bile duct cancer market over the forecast period. For instance, Leap therapeutics, in 2015, reported development of DKN-01, a humanized monoclonal antibody. It is under clinical trial phase I for treatment of bile duct cancer through its anti-neoplastic activity.
Global Bile Duct Cancer Market: Opportunitiesย
R&D of new drugs is expected to offer lucrative growth opportunities for players in the global bile duct cancer market over the forecast period. For instance, Merck Sharp & Dohme Corp, in September 2019, started a clinical trial to assess the efficacy of Pembrolizumab (immunotherapy) in combination with Gemcitabine/Cisplatin for the treatment of bile duct cancer.
Global Bile Duct Cancer Market: Restraintsย
Growth of the global bile duct cancer market is limited due to high cost associated with the treatment of bile duct cancer. For example, the total cost of treatment for bile duct cancer increased from US$ 36,460 in 1997 to US$ 77,753 in 2012, according to the U.S. National Library of Medicine report 2017. Moreover, cancer treatment (including chemotherapy, targeted therapy, and others) related costs in the U.K. are approximately 0.1 to 0.15% of GDP or accounts 20 to 25% for oncology treatments, according to the data published in UCL School of Pharmacy report 2020.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4790
Global Bile Duct Cancer Market: Competitive Landscape
Major players operating in the global bile duct cancer market include, Ability Pharmaceuticals, Agios Pharmaceuticals, Inc., Delcath Systems, Inc., Eisai Co., Ltd., Imbrium Therapeutics L.P., Incyte Corporation, QED Therapeutics, Inc., and RenovoRx.
Global Bile Duct Cancer Market: Key Developmentsย
Major players operating in the global bile duct cancer market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, QED Therapeutics, in Mach 2021, collaborated with Helsinn Group to co-develop and commercialize Infigratinib, an oral FGFR1-3 selective inhibitor, for patients dealing with bile duct cancer.
Global Bile Duct Cancer Market: Segmentationย
By Treatment Type:
- Chemotherapy
- Gemcitabine
- Cisplatin
- Oxaliplatin
- Capecitabine
- 5 fluorouracil (5-FU)
- Targeted Therapy
- Pemigatinib
- Infigratinib (Phase 3)
- Ivosidenib (Phase 3)
- Immunotherapy
- Pembrolizumab (Phase 3)
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Buy This Research Study Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/4790
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Brand Analysis
- Global Bile Duct Cancer market โ Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Bile Duct Cancer market, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 โ 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Gemcitabine
- Cisplatin
- Oxaliplatin
- Oxaliplatin
- 5 fluorouracil (5-FU)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Pemigatinib
- Infigratinib (Phase 3)
- Ivosidenib (Phase 3)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Pembrolizumab (Phase 3)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Introduction
- Global Bile Duct Cancer market, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 โ 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Mn)
- Introduction
- Global Bile Duct Cancer market, By Region, 2021 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018โ2028
- North America
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2021 โ 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2021 โ 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2021 โ 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2021 โ 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2021 โ 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Treatment Type, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 โ 2028, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2021 โ 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/bile-duct-cancer-market-4050
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837